Neogen Corporation Reports $222.8 Million Revenue with 6.5% Year-Over-Year Growth

Neogen Corporation reported a total revenue of $222.8 million for the three months ended August 31, 2026, marking a 6.5% increase from $209.2 million in the same period last year. This growth was primarily driven by a $16.9 million increase in product revenues, particularly in the pathogen detection product line, and a favorable foreign exchange impact of $1.6 million. However, this was partially offset by a $4.9 million decline due to the divestiture of the Cleaners and Disinfectants business. The company's gross profit also increased to $105.5 million, resulting in a gross margin of 47.4%, up from 45.4% a year earlier.

In terms of profitability, Neogen reported a net loss of $11.9 million, or $(0.05) per share, compared to a net income of $36.3 million, or $0.17 per share, in the prior year. The significant decline in net income was attributed to a $76.4 million gain recognized in the previous year from the sale of the Cleaners and Disinfectants business, which did not recur in the current period. Operating expenses decreased to $107.3 million from $111.1 million, driven by lower sales and marketing costs and general administrative expenses, although research and development expenses increased.

Neogen's operational developments included a focus on restructuring initiatives aimed at enhancing commercial operations and reducing costs. The company reported a reduction in headcount by approximately 10% as part of its strategy to streamline operations. Additionally, the company is in the process of divesting its Genomics business, with a definitive agreement to sell to Zoetis Inc. for $160 million, pending regulatory approvals. This divestiture is part of Neogen's strategy to concentrate on its core food and animal safety segments.

Geographically, Neogen's international sales rose to $112.7 million, up from $107.1 million, driven by increased sales in Asia and Latin America. The Food Safety segment generated $163.2 million in revenue, reflecting a 7.3% increase, while the Animal Safety segment saw a 4.4% increase to $59.6 million. The company continues to leverage its distribution relationships and has reported improvements in operational efficiencies, particularly in the Animal Safety segment.

Looking ahead, Neogen remains optimistic about its growth prospects, focusing on enhancing its product portfolio and operational efficiencies. The company anticipates that ongoing restructuring efforts and strategic investments in research and development will support future revenue growth. However, Neogen also acknowledges the challenges posed by inflationary pressures, elevated interest rates, and geopolitical tensions, which may impact its financial performance in the near term.